The technology is designed to simplify the bio-separation process while reducing manufacturing costs.

At the 2024 annual meeting of the International Society for Cell & Gene Therapy (ISCT) in Vancouver, Canada, Hélio Tomás, PhD, senior research associate at the Instituto de Biologia Experimental e ...

The life science group Sartorius is launching an integrated system for the production and quality control (QC) of autologous cell therapies.

ImmunityBio (NASDAQ: IBRX), a commercial-stage immunotherapy company, today announced the successful completion of manufacturing engineering programs, NK2022 and NK2023, establishing a safe, ...

Three Japanese companies say they will work together to convert electrolysis cell production scrap into pure titanium.

Pharmaceutical companies are shifting from the development of autologous cell therapies to allogeneic cell therapies.

LONDON--(BUSINESS WIRE)--Mytos, an innovative leader in automated cell manufacturing, announced today it has closed $19M in Series A financing led by Buckley Ventures, with participation from IQ ...

Asahi Kasei, a diversified global company, Nippon Steel, and Nippon Steel Trading have launched a recycling initiative to convert pure titanium scrap generated during the manufacturing of electrolysis ...

Elegen, a global leader in next-generation DNA manufacturing, and Nutcracker Therapeutics, a global leader in next-generation RNA design and manufacturing, today announced the launch of a pilot ...

Solid-state battery developer QuantumScape shared another exciting milestone today: integrating its long-developed “Cobra” solid-state separator manufacturing process into its baseline production.

Korea University researchers have developed a machine-learning framework that predicts solar cell efficiency from wafer quality, enabling early wafer screening and optimized production paths. Using ...